Merck West Point Timeliness Of Corrective Actions Cited In FDA Letter

The timeliness of Merck's West Point facility to respond to good manufacturing practice problems is among deficiencies cited in a June 16 FDA warning letter to the company.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet